FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022272075> ?p ?o ?g. }

• W2022272075 endingPage "174" @default.
• W2022272075 startingPage "169" @default.
• W2022272075 abstract "The purpose of this study was to evaluate the biological significance of Ki67 antigen expression in serous ovarian tumors, through the analysis of MIB 1 monoclonal antibody reactivity in cystoadenomas, borderline tumors, and invasive cystoadenocarcinomas; the correlation between this index of cell proliferation and clinicopathologic parameters (FIGO stage and grade, and disease-free survival) was also investigated in invasive cystoadenocarcinomas. Fifty-four patients with serous ovarian tumors, treated at the Institute of Gynecologic and Obstetrics, Ancona University, Italy, were used as study population; 10 women had serous cystoadenoma, 16 women had serous borderline tumor, and 28 women had invasive cystoadenocarcinoma. The expression of primary tumor proliferation related to Ki67 antigen was immunohistochemically evaluated by monoclonal MIB 1 antibody (Immunotech, Marseille Cedex, France) on microwave oven-processed formalin-fixed paraffin-embedded tissue. Compared to cystoadenomas and borderline tumors, the tissular Ki67 antigen immunostaining was significantly higher in cystoadenocarcinomas, with the highest values in architectural grade 2 and 3 neoplasms (P < 0.001). Within the cystoadenocarcinomas, a relationship was observed between the measured proliferation index and disease FIGO stage, but it was not significant (P = 0.92). However, patients who recurred and/or had disease progression presented a primitive neoplasm with significantly higher expression of Ki67 antigen than that of patients with disease-free survival (P = 0.01). A significant relationship was observed between the Ki67 index and disease-free survival, independent of histologic grade and stage, evaluated by Cox hazards analysis (P = 0.02). The proliferation index detected by Ki67 antigen immunostaining may represent an indicator of aggressiveness in serous ovarian tumors and an additionally useful prognostic factor in cystoadenocarcinomas, probably independent of and apparently more significant than the tumor architectural grade and the disease FIGO stage." @default.
• W2022272075 created "2016-06-24" @default.
• W2022272075 creator A5007186416 @default.
• W2022272075 creator A5019528189 @default.
• W2022272075 creator A5021892261 @default.
• W2022272075 creator A5024661860 @default.
• W2022272075 creator A5049079247 @default.
• W2022272075 creator A5055586778 @default.
• W2022272075 creator A5058356885 @default.
• W2022272075 date "1995-02-01" @default.
• W2022272075 modified "2023-09-27" @default.
• W2022272075 title "Ki67 Antigen Immunostaining (MIB 1 Monoclonal Antibody) in Serous Ovarian Tumors: Index of Proliferative Activity with Prognostic Significance" @default.
• W2022272075 doi "https://doi.org/10.1006/gyno.1995.1026" @default.
• W2022272075 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7896180" @default.
• W2022272075 hasPublicationYear "1995" @default.
• W2022272075 type Work @default.
• W2022272075 sameAs 2022272075 @default.
• W2022272075 citedByCount "94" @default.
• W2022272075 countsByYear W20222720752012 @default.
• W2022272075 countsByYear W20222720752013 @default.
• W2022272075 countsByYear W20222720752014 @default.
• W2022272075 countsByYear W20222720752015 @default.
• W2022272075 countsByYear W20222720752016 @default.
• W2022272075 countsByYear W20222720752017 @default.
• W2022272075 countsByYear W20222720752018 @default.
• W2022272075 countsByYear W20222720752019 @default.
• W2022272075 countsByYear W20222720752020 @default.
• W2022272075 countsByYear W20222720752021 @default.
• W2022272075 countsByYear W20222720752023 @default.
• W2022272075 crossrefType "journal-article" @default.
• W2022272075 hasAuthorship W2022272075A5007186416 @default.
• W2022272075 hasAuthorship W2022272075A5019528189 @default.
• W2022272075 hasAuthorship W2022272075A5021892261 @default.
• W2022272075 hasAuthorship W2022272075A5024661860 @default.
• W2022272075 hasAuthorship W2022272075A5049079247 @default.
• W2022272075 hasAuthorship W2022272075A5055586778 @default.
• W2022272075 hasAuthorship W2022272075A5058356885 @default.
• W2022272075 hasConcept C121608353 @default.
• W2022272075 hasConcept C126322002 @default.
• W2022272075 hasConcept C142724271 @default.
• W2022272075 hasConcept C146357865 @default.
• W2022272075 hasConcept C147483822 @default.
• W2022272075 hasConcept C150173356 @default.
• W2022272075 hasConcept C151730666 @default.
• W2022272075 hasConcept C159654299 @default.
• W2022272075 hasConcept C203014093 @default.
• W2022272075 hasConcept C204232928 @default.
• W2022272075 hasConcept C2777751288 @default.
• W2022272075 hasConcept C2778324911 @default.
• W2022272075 hasConcept C2780084626 @default.
• W2022272075 hasConcept C2780427987 @default.
• W2022272075 hasConcept C2908647359 @default.
• W2022272075 hasConcept C2910938049 @default.
• W2022272075 hasConcept C4224716 @default.
• W2022272075 hasConcept C542903549 @default.
• W2022272075 hasConcept C71924100 @default.
• W2022272075 hasConcept C86803240 @default.
• W2022272075 hasConcept C99454951 @default.
• W2022272075 hasConceptScore W2022272075C121608353 @default.
• W2022272075 hasConceptScore W2022272075C126322002 @default.
• W2022272075 hasConceptScore W2022272075C142724271 @default.
• W2022272075 hasConceptScore W2022272075C146357865 @default.
• W2022272075 hasConceptScore W2022272075C147483822 @default.
• W2022272075 hasConceptScore W2022272075C150173356 @default.
• W2022272075 hasConceptScore W2022272075C151730666 @default.
• W2022272075 hasConceptScore W2022272075C159654299 @default.
• W2022272075 hasConceptScore W2022272075C203014093 @default.
• W2022272075 hasConceptScore W2022272075C204232928 @default.
• W2022272075 hasConceptScore W2022272075C2777751288 @default.
• W2022272075 hasConceptScore W2022272075C2778324911 @default.
• W2022272075 hasConceptScore W2022272075C2780084626 @default.
• W2022272075 hasConceptScore W2022272075C2780427987 @default.
• W2022272075 hasConceptScore W2022272075C2908647359 @default.
• W2022272075 hasConceptScore W2022272075C2910938049 @default.
• W2022272075 hasConceptScore W2022272075C4224716 @default.
• W2022272075 hasConceptScore W2022272075C542903549 @default.
• W2022272075 hasConceptScore W2022272075C71924100 @default.
• W2022272075 hasConceptScore W2022272075C86803240 @default.
• W2022272075 hasConceptScore W2022272075C99454951 @default.
• W2022272075 hasIssue "2" @default.
• W2022272075 hasLocation W20222720751 @default.
• W2022272075 hasLocation W20222720752 @default.
• W2022272075 hasOpenAccess W2022272075 @default.
• W2022272075 hasPrimaryLocation W20222720751 @default.
• W2022272075 hasRelatedWork W1546067550 @default.
• W2022272075 hasRelatedWork W1999396441 @default.
• W2022272075 hasRelatedWork W1999402440 @default.
• W2022272075 hasRelatedWork W2011115754 @default.
• W2022272075 hasRelatedWork W2017794333 @default.
• W2022272075 hasRelatedWork W2022272075 @default.
• W2022272075 hasRelatedWork W2053181077 @default.
• W2022272075 hasRelatedWork W2077889364 @default.
• W2022272075 hasRelatedWork W2196039382 @default.
• W2022272075 hasRelatedWork W2413359840 @default.
• W2022272075 hasVolume "56" @default.
• W2022272075 isParatext "false" @default.
• W2022272075 isRetracted "false" @default.
• W2022272075 magId "2022272075" @default.

• next